U.S. Congress legislation · 119th Congress
HB1266: Combating Illicit Xylazine Act
Status: Passed one chamber, September 16, 2026
To prohibit certain uses of xylazine, and for other purposes.
What the bill says
An act To prohibit certain uses of xylazine, and for other purposes.
From the amended text, September 16, 2026:
AN ACT To prohibit certain uses of xylazine, and for other purposes. SECTION 1. Short title This Act may be cited as the Combating Illicit Xylazine Act . SECTION 2. Definitions (a) In general In this Act, the term xylazine has the meaning given the term in paragraph (61) of section 102 of the Controlled Substances Act, as added by subsection (b) of this section. (b) Controlled substances act Section 102 of the Controlled Substances Act ( 21 U.S.C. 802 ) is amended by adding at the end the following: (61) The term xylazine means the substance xylazine, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible. . SECTION 3. Adding xylazine to schedule III Schedule III of section 202(c) of the Controlled Substances Act ( 21 U.S.C. 812 ) is amended by adding at the end the following: (f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of xylazine. . SECTION 4. Amendments (a) Amendment Section 102 of the Controlled Substances Act ( 21 U.S.C. 802 ) is amended by striking paragraph (27) and inserting the or (bb) a pharmacy registered under this Act pursuant to a prescription of a veterinarian registered under this Act; and …
Sponsors
- Jimmy Panetta (D) · primary sponsor
- August Pfluger (R, HD-011)
- Gus Bilirakis (R, HD-FL-12)
- Christopher Pappas (D, HD-001)
- Scott Fitzgerald (R, HD-005)
- Deborah Ross (D, HD-002)
- Dan Crenshaw (R, HD-002)
- Josh Harder (D, HD-CA-9)
- Suzan DelBene (D, HD-001)
- Mariannette Miller-Meeks (R, HD-001)
- Brittany Pettersen (D, HD-007)
- Yvette Clarke (D, HD-009)
Latest actions
- : Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.
- : Motion to reconsider laid on the table Agreed to without objection.
- : On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5671-5672)
- : Considered under suspension of the rules. (consideration: CR H5671-5673)
- : On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
- : Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
- : DEBATE - The House proceeded with forty minutes of debate on H.R. 1266.
- : Considered under suspension of the rules.
- : Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
- : Placed on the Union Calendar, Calendar No. 715.
Subjects: Criminal procedure and sentencing, Consumer affairs, Manufacturing, U.S. Sentencing Commission, Licensing and registrations, Crime and Law Enforcement, Drug safety, medical device, and laboratory regulation, Veterinary medicine and animal diseases
Common questions
- What is HB1266?
- HB1266 is a bill in Congress (119th Congress): Combating Illicit Xylazine Act.
- What does HB1266 do?
- In its own words: An act To prohibit certain uses of xylazine, and for other purposes.
- What is the status of HB1266?
- Passed one chamber as of September 16, 2026. Latest action: Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623. (September 16, 2026).
- Who sponsored HB1266?
- Jimmy Panetta (D), with 11 co-sponsors.
- Where is the official record for HB1266?
- On the Congress website: https://www.congress.gov/bill/119th-congress/house-bill/1266
Source: official Congress record. Tracked by Delilah, AI for legislation across all 50 states and Congress.